Weekly digest: what’s happening in open science?

As the UK and much of Europe face a second wave of COVID-19 and local lockdowns, we at Open Pharma continue to hope that all our readers are staying safe and well. We also know that the deluge of information on the COVID-19 outbreak can be incredibly taxing on our mental health so, throughout this period, we have been including links to several well-being resources at the bottom of each weekly digest and will continue to do so. We at Open Pharma would again like to encourage all our readers to look after themselves and their community, to wear a mask and to continue to follow advice from their country’s government and health organizations.

Weekly digest: what’s happening in open science?

Featuring the latest signatory of Plan S, a think piece outlining the future of scholarly communications as the industry moves towards an open publishing model, the results from a survey on the economic impact of COVID-19 on professional societies, a new policy on price transparency from Gates Open Research and an analysis of figshare metadata on the usage of open research data.

Weekly digest: what’s happening in open science?

Featuring the advent of ‘little’ subscription deals for libraries, a reminder of the upcoming Open Access Week panel discussion, a new upload to our figshare, a new trans-inclusive policy from F1000Research and Wellcome Open Research, further commitments to scientific integrity from vaccine developers, and the best and worst institutions in the USA for clinical trial transparency.

Weekly digest: what’s happening in open science?

Featuring an open letter from pharma, the theme of Open Access Week 2020, a new publishing partnership between Hindawi and SAGE Publishing, a metrics-based study on open access and social media engagement, a call for systematizing journal databases and directories, discussions regarding sustainable open source alternatives and Molecular Biology of the Cell’s transition to a Subscribe To Open subscription model.